Related Experiment Video
Updated: Jun 21, 2025
13:04
Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR
Published on: March 1, 2019
8.9K
The function of long non-coding RNA IFNG-AS1 in autoimmune diseases
Jiale Zhao1,2,3, Yibei Gui1,3,4, Wei Wu1,2,3
1Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, 443002, China.
Human Cell
|July 14, 2024
Summary
Long non-coding RNAs (lncRNAs) are vital in immune cell function and autoimmune diseases. This study investigates the role of IFNG-AS1, a specific lncRNA, in autoimmune disease pathogenesis and its therapeutic potential.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- Autoimmune diseases are a major global health concern, ranking third in prevalence worldwide.
- Long non-coding RNAs (lncRNAs) are critical regulators of gene expression and immune cell function.
- Dysregulation of lncRNAs, including IFNG-AS1, is increasingly linked to autoimmune disorders.
Purpose of the Study:
- To examine the specific role and regulatory mechanisms of IFNG-AS1 in various autoimmune diseases.
- To evaluate the potential of IFNG-AS1 as a therapeutic target for autoimmune conditions.
Main Methods:
- Literature review and analysis of existing studies on IFNG-AS1 and autoimmune diseases.
- Exploration of IFNG-AS1's function in immune cell regulation and its association with disease pathogenesis.
Main Results:
- IFNG-AS1, also known as NeST or TMEVPG1, is a key immune regulatory factor located near the IFNG gene.
- Evidence suggests IFNG-AS1 dysregulation contributes to the development of several autoimmune diseases.
- IFNG-AS1 plays a crucial role in the immune system's response and is implicated in autoimmune pathogenesis.
Conclusions:
- IFNG-AS1 is a significant factor in the pathogenesis of autoimmune diseases.
- Targeting IFNG-AS1 presents a promising therapeutic strategy for managing autoimmune disorders.
More Related Videos
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
5.9K
10:00High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
13.4K
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
02:30siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
02:15Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
01:24T Cell Types and Functions
996
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
996
02:26NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
01:29Autoimmune Disorders
409
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
409